Skip to content
10-Q

Quarterly Report

ARGOS THERAPEUTICS INC

0001171843-18-006192

← back to feed
Filed
Aug 20, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 17, 2018 10.59M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$10.78M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$24.14M
Long Term Debt Q2 2018 · Jun 30, 2018 $12.13M
Long Term Debt Q2 2018 · Dec 31, 2017 $12.13M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $12.13M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $15.19M
Cash And Equivalents Q2 2018 · Jun 30, 2017 $9.34M
Cash And Equivalents Q2 2018 · Dec 31, 2016 $52.97M
Stockholders Equity Q2 2018 · Jun 30, 2018 −$8.14M
Stockholders Equity Q2 2018 · Dec 31, 2017 −$9.23M
Current Liabilities Q2 2018 · Jun 30, 2018 $9.5M
Current Liabilities Q2 2018 · Dec 31, 2017 $9.56M
Current Assets Q2 2018 · Jun 30, 2018 $14.17M
Current Assets Q2 2018 · Dec 31, 2017 $17.18M
Total Assets Q2 2018 · Jun 30, 2018 $16.79M
Total Assets Q2 2018 · Dec 31, 2017 $20.78M
Sga Expense Q2 2018 · Jun 30, 2018 $2.5M
Sga Expense Q2 2018 · Jun 30, 2018 $4.99M
Sga Expense Q2 2018 · Jun 30, 2017 $2.68M
Sga Expense Q2 2018 · Jun 30, 2017 $6.64M
Rd Expense Q2 2018 · Jun 30, 2018 $3.92M
Rd Expense Q2 2018 · Jun 30, 2018 $9.47M
Rd Expense Q2 2018 · Jun 30, 2017 $5.12M
Rd Expense Q2 2018 · Jun 30, 2017 $13.03M
Net Income Q2 2018 · Jun 30, 2018 −$6.48M
Net Income Q2 2018 · Jun 30, 2018 −$8.59M
Net Income Q2 2018 · Jun 30, 2017 −$8.54M
Net Income Q2 2018 · Jun 30, 2017 −$32.62M
Operating Income Q2 2018 · Jun 30, 2018 −$6.37M
Operating Income Q2 2018 · Jun 30, 2018 −$8.48M
Operating Income Q2 2018 · Jun 30, 2017 −$8.08M
Operating Income Q2 2018 · Jun 30, 2017 −$52.06M
Capex Q2 2018 · Jun 30, 2017 $3.6M